Pfizer Inc Cancellation of UK Listing (2153X)
22 Février 2017 - 8:00AM
UK Regulatory
TIDMPFZ
RNS Number : 2153X
Pfizer Inc
22 February 2017
Pfizer Inc. to cancel listing in the United Kingdom
22 February 2017
Pfizer Inc. (NYSE:PFE) (the "Company") today announced that it
has applied to the United Kingdom Listing Authority ("UKLA") to
cancel the standard listing of the Company's common stock ("Common
Stock") from the Official List of the UKLA and the cancellation of
trading in the Company's Common Stock on the Main Market of the
London Stock Exchange (together, the "Cancellation"), following a
determination by the Company that there is limited trading or
liquidity of its Common Stock on the Main Market of the London
Stock Exchange. The Company also announced today that it will be
cancelling the listing of its Common Stock from the SIX Swiss
Exchange for the same reasons.
The effective date of the Cancellation is intended to be 23
March 2017. Following the de-listing, the Company will continue to
list its Common Stock on the New York Stock Exchange under the
symbol "PFE".
***
Contact
Media:
Joan Campion, + 1.212-733-2798
Joan.Campion@pfizer.com
Investor:
Chuck Triano, +1 212-733-3901
Charles.E.Triano@pfizer.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCBXGDDISBBGRR
(END) Dow Jones Newswires
February 22, 2017 02:00 ET (07:00 GMT)
Pfizer (LSE:PFZ)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Pfizer (LSE:PFZ)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024
Real-Time news about Pfizer (London Stock Exchange): 0 recent articles
Plus d'articles sur Pfizer